ClinicalTrials.govpublic full text
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
prostate cancer, hormone refractory, metastatic, localized, locally advanced, prostate cancer - high risk localized or locally advanced, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859234
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.